White House Plans to Supercharge Science, But Critics Warn of Research Drought

White House Plans to Supercharge Science, But Critics Warn of Research Drought

The Trump administration is pushing a major expansion of American science while moving research funding away from universities, prompting warnings that basic research could suffer.

· 2 min read ·

The Trump administration has announced an ambitious plan to greatly increase the speed and scale of scientific discovery in the United States, with officials framing the effort as a push toward a new "Golden Age of Science" [268415]. The initiative aims to accelerate innovation across multiple scientific fields and strengthen the country's position in global research and development [268415].

At the same time, U.S. science leaders are pushing back against a White House plan to shift research funding away from universities and toward private industry [263254]. They warn the move could cause a drought in basic research—the early-stage science that often leads to major breakthroughs [263254].

Basic research is the study of fundamental questions without a specific product or profit in mind, and universities have long been its main home [263254]. Science leaders argue that private companies tend to fund applied research targeting near-term commercial products, and that without universities, the pipeline of new discoveries could run dry [263254]. The White House has not announced final details of the funding plan [263254].

The administration's science push extends to specific health priorities as well. Melania Trump announced a new research and policy initiative that she said will set "a new standard for women's health" [266449]. President Donald Trump ordered the creation of a new National Institutes of Health division and a task force focused on women's health, aiming to coordinate research and policy across the federal government [266449].

The administration is also moving to allow compounding pharmacies to produce certain peptides, according to a report from STAT's Pharmalittle newsletter [264521]. Compounding pharmacies mix custom medications for individual patients, and the plan would let them make specific peptides—short chains of amino acids—that are not currently approved for general use [264521].

Separately, a new method for comparing national research systems could change how governments judge the strength of their science [266441]. The approach offers a way to measure research performance across countries and identify where improvements are needed, looking at research output, quality, and impact relative to each country's resources [266441].

The analysis suggests steps countries can take to strengthen their research systems, including better funding strategies, stronger institutions, and closer links between research and industry [266441].

Sources

Related